ARDX
Price
$4.82
Change
+$0.13 (+2.77%)
Updated
Dec 20, 04:59 PM (EDT)
74 days until earnings call
MLTX
Price
$52.08
Change
+$0.20 (+0.39%)
Updated
Dec 20, 04:59 PM (EDT)
93 days until earnings call
Ad is loading...

ARDX vs MLTX

Header iconARDX vs MLTX Comparison
Open Charts ARDX vs MLTXBanner chart's image
Ardelyx
Price$4.82
Change+$0.13 (+2.77%)
Volume$61.88K
CapitalizationN/A
MoonLake Immunotherapeutics
Price$52.08
Change+$0.20 (+0.39%)
Volume$3.4K
CapitalizationN/A
ARDX vs MLTX Comparison Chart
Loading...
ARDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARDX vs. MLTX commentary
Dec 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARDX is a Hold and MLTX is a Hold.

COMPARISON
Comparison
Dec 21, 2024
Stock price -- (ARDX: $4.82 vs. MLTX: $52.17)
Brand notoriety: ARDX and MLTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARDX: 109% vs. MLTX: 93%
Market capitalization -- ARDX: $1.14B vs. MLTX: $3.29B
ARDX [@Biotechnology] is valued at $1.14B. MLTX’s [@Biotechnology] market capitalization is $3.29B. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARDX’s FA Score shows that 0 FA rating(s) are green whileMLTX’s FA Score has 0 green FA rating(s).

  • ARDX’s FA Score: 0 green, 5 red.
  • MLTX’s FA Score: 0 green, 5 red.
According to our system of comparison, MLTX is a better buy in the long-term than ARDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARDX’s TA Score shows that 4 TA indicator(s) are bullish while MLTX’s TA Score has 5 bullish TA indicator(s).

  • ARDX’s TA Score: 4 bullish, 3 bearish.
  • MLTX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, MLTX is a better buy in the short-term than ARDX.

Price Growth

ARDX (@Biotechnology) experienced а -7.76% price change this week, while MLTX (@Biotechnology) price change was +1.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

ARDX is expected to report earnings on Mar 05, 2025.

MLTX is expected to report earnings on Mar 24, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($3.29B) has a higher market cap than ARDX($1.14B). MLTX YTD gains are higher at: -13.612 vs. ARDX (-22.339). ARDX has higher annual earnings (EBITDA): -53.06M vs. MLTX (-108.45M). MLTX has more cash in the bank: 494M vs. ARDX (190M). MLTX has less debt than ARDX: MLTX (3.69M) vs ARDX (104M). ARDX has higher revenues than MLTX: ARDX (252M) vs MLTX (0).
ARDXMLTXARDX / MLTX
Capitalization1.14B3.29B35%
EBITDA-53.06M-108.45M49%
Gain YTD-22.339-13.612164%
P/E RatioN/AN/A-
Revenue252M0-
Total Cash190M494M38%
Total Debt104M3.69M2,820%
FUNDAMENTALS RATINGS
ARDX: Fundamental Ratings
ARDX
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
79
P/E GROWTH RATING
1..100
50
SEASONALITY SCORE
1..100
28

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARDXMLTX
RSI
ODDS (%)
Bullish Trend 5 days ago
88%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
68%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
51%
MACD
ODDS (%)
Bearish Trend 1 day ago
71%
Bearish Trend 1 day ago
48%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
75%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
75%
Advances
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 5 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 3 days ago
69%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
63%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Ad is loading...
ARDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IGMAX7.590.09
+1.20%
Voya Global Insights Portfolio ADV
RFNBX80.560.73
+0.91%
American Funds Fundamental Invs R2
MAFGX43.36N/A
N/A
BlackRock Capital Appreciation Instl
CVFYX15.07N/A
N/A
Pioneer Disciplined Value Y
FHEQX13.41N/A
N/A
Federated Hermes SDG Engagement Eq A

ARDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARDX has been loosely correlated with VCYT. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ARDX jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARDX
1D Price
Change %
ARDX100%
+2.67%
VCYT - ARDX
45%
Loosely correlated
+4.66%
HRTX - ARDX
41%
Loosely correlated
+2.61%
PTGX - ARDX
40%
Loosely correlated
+4.93%
XENE - ARDX
40%
Loosely correlated
-0.54%
NKTX - ARDX
39%
Loosely correlated
+7.73%
More

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been loosely correlated with XENE. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if MLTX jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
+0.56%
XENE - MLTX
41%
Loosely correlated
-0.54%
EDIT - MLTX
41%
Loosely correlated
-2.24%
AXSM - MLTX
40%
Loosely correlated
+1.16%
DNLI - MLTX
39%
Loosely correlated
-0.14%
CRNX - MLTX
39%
Loosely correlated
+1.44%
More